Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Blood System Drugs (Find 85 items)

Blood System Drugs

Rivaroxaban

(366789-02-8)
A novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor Used in adult patients with elective hip or knee replacement surgery to prevent venous thrombosis

Product List

Request for quotation , get quotes from more suppliers.

Dextran

(9004-54-0)
Substance is used in soft center confections, as a partial substitute for barley malt. Anti-anemia drugs. Used for iron deficiency anemia. Adverse reactions and contraindications If the hemoglobin does not gradually increase after injection of this product, the drug should be stopped immediately. Avoid use in patients with liver and kidney dysfunction. Blood volume supplement medicine. Adverse reactions and contraindications occasionally allergic reactions. It is forbidden for patients with con

Product List

Request for quotation , get quotes from more suppliers.

Anethole

(104-46-1)
Accounts for the distinctive licorice flavor of anise, fennel, star anise, and anise myrtle. Used as flavor and spice for toothpaste, also used in food, medicine, etc. Used in daily chemicals, medicine, food

Product List

Request for quotation , get quotes from more suppliers.

Dabigatran

(211914-51-1)
Nonpeptide, direct thrombin inhibitor. Antithrombotic.

Product List

Request for quotation , get quotes from more suppliers.

6-Aminohexanoic acid

(60-32-2)
EACA is directly soluble in water at 25 mg/ml. As an inhibitor of plasmin it is has been utilized in the clotting buffer for fibrinogen assays. This buffer is 10 mM potassium and sodium phosphate, pH 6.4, with 0.20 g CaCl2, 5 g 6-Aminohexanoic acid, 1 g sodium azide, and 9 g NaCl in 1 liter. The buffer is stable indefinitely at room temperature.

Product List

Request for quotation , get quotes from more suppliers.

Ticagrelor

(274693-27-5)
Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist, also inhibits CYP2C9 and 4-hydroxylation with IC50 of 10.5 μM and 8.2 μM respectively

Product List

Request for quotation , get quotes from more suppliers.

Prasugrel

(150322-43-3)
Prasugrel is a thienopyridine prodrug that is converted by esterases to a receptor antagonist for purinergic P2Y12 receptors. The blockade of P2Y12 receptor activation prevents platelet aggregation. Prasugrel is metabolized by the liver- and intestinal-dominant carboxylesterases CE1 and CE2 to give a mixture of four enantiomers that inhibit platelet aggregation.[Cayman Chemical]

Product List

Request for quotation , get quotes from more suppliers.

Dabigatran etexilate

(211915-06-9)
BIBR-1048 (Dabigatran) is an anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in many cases it offers an alternative to warfarin as the preferred orally administered blood thinner sin

Product List

Request for quotation , get quotes from more suppliers.

Cilostazol

(73963-72-1)
A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake.Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo.Also affects lipid levels in vivo

Product List

Request for quotation , get quotes from more suppliers.

Ferrous gluconate

(299-29-6)
Iron(II) gluconate, or ferrous gluconate, is a black compound often used as an iron supplement. It is the iron(II) salt of gluconic acid. It is marketed under brand names such as Fergon, Ferralet, and Simron.

Product List

Request for quotation , get quotes from more suppliers.

Hematological diseases refer to diseases that are primary (such as leukemia) or mainly involve blood (such as iron deficiency anemia) and hematopoietic organs. Classification: red blood cell diseases, such as various types of anemia and polycythemia, etc .; granulocyte diseases, such as leukopenia and agranulocytosis, neutrophil lobular insufficiency, inert leukocyte syndrome, and leukemia-like reactions. Blood system drugs mainly include: anti-anemic drugs, leukocyte-raising drugs, antiplatelet drugs, procoagulant drugs, anticoagulant drugs and thrombolytic drugs, blood volume expansion agents, leukocyte-raising drugs, antiplatelet drugs and other drugs. The "Blood System Drugs" on ECHEMI classification list mainly supplies APIs for these drugs.
Complaint
Email:
Message:
Send Message